Literature DB >> 24381101

Variations in the GST activity are associated with single and combinations of GST genotypes in both male and female diabetic patients.

Durga Koteswara Rao1, Noor Ahmad Shaik, Ahmad Imran, Dwarakanath K Murthy, Eswar Ganti, Chitralekha Chinta, Hanmantha Rao, Nazia Sultana Shaik, Jumana Yousuf Al-Aama.   

Abstract

In the present cross sectional study, we aimed to ascertain the relative associations of GST genotypes with GST activity variations and also with the risk to DMT2 predisposition among men and women separately. Clinical samples obtained from 244 DMT2 cases (120 Males and 124 Females) and 228 controls (117 Males and 111 Females) belonging to Asian Indian ethnicity were used to test for glycemic index, lipid profile, GST activity and GST genotypes. The frequencies of single and combinations of GST genotypes were statistically examined for their association with DMT2 risk among both study groups. The GST activity is significantly lowered in DMT2 group compared to controls (p = < 0.001). This reduction is found to be subjective to single and combinations of GST genotypes among diabetic patients. The frequency distribution for single, double and triple combinations of genotypes of GSTT1, GSTM1 and GSTP1 showed the varying degrees of association with DMT2 risk from 0.5 to 5.6-fold among male and female patients (for all associations, p value was <0.05). Interestingly, GST activity was lowered in both male and female patients with single or combinational genotypes of GSTM1 (Null), GSTT1 (Null), and P1 (V/V) (for all associations, p value was = <0.0001). The reduced anti-oxidant capacity among diabetic patients with certain GST genotypes may have some important implications for disease diagnosis and therapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24381101     DOI: 10.1007/s11033-013-2924-5

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  41 in total

1.  Development of a rapid and sensitive immunofluorometric assay for glutathione S-transferase A.

Authors:  L K Dajani; E Paus; D J Warren
Journal:  Clin Chem       Date:  2001-05       Impact factor: 8.327

2.  Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study.

Authors:  John F Keaney; Martin G Larson; Ramachandran S Vasan; Peter W F Wilson; Izabella Lipinska; Diane Corey; Joseph M Massaro; Patrice Sutherland; Joseph A Vita; Emelia J Benjamin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-01-30       Impact factor: 8.311

3.  Rapid spectrophotometric method for serum glutathione S-transferases activity.

Authors:  Mohammed Habdous; Monique Vincent-Viry; Sophie Visvikis; Gérard Siest
Journal:  Clin Chim Acta       Date:  2002-12       Impact factor: 3.786

4.  Variability of glutathione S-transferase alpha in human liver and plasma.

Authors:  T P Mulder; D A Court; W H Peters
Journal:  Clin Chem       Date:  1999-03       Impact factor: 8.327

5.  Body fat distribution and their associations with cardiovascular risk, insulin resistance and β-cell function: are there differences between men and women?

Authors:  G Chen; C Liu; F Chen; J Yao; Q Jiang; N Chen; H Huang; J Liang; L Li; L Lin
Journal:  Int J Clin Pract       Date:  2011-05       Impact factor: 2.503

6.  Glutathione S-transferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility.

Authors:  S Zhong; A F Howie; B Ketterer; J Taylor; J D Hayes; G J Beckett; C G Wathen; C R Wolf; N K Spurr
Journal:  Carcinogenesis       Date:  1991-09       Impact factor: 4.944

Review 7.  The glutathione S-transferases: influence of polymorphism on cancer susceptibility.

Authors:  R C Strange; A A Fryer
Journal:  IARC Sci Publ       Date:  1999

8.  Sex differences in diabetes risk and the effect of intensive lifestyle modification in the Diabetes Prevention Program.

Authors:  Leigh Perreault; Yong Ma; Sam Dagogo-Jack; Edward Horton; David Marrero; Jill Crandall; Elizabeth Barrett-Connor
Journal:  Diabetes Care       Date:  2008-03-20       Impact factor: 19.112

9.  Glutathione S-transferase P1 genotypes, genetic susceptibility and outcome of therapy in thai childhood acute lymphoblastic leukemia.

Authors:  Jiraporn Gatedee; Samart Pakakassama; Sunsiree Muangman; Wanida Pongstaporn
Journal:  Asian Pac J Cancer Prev       Date:  2007 Apr-Jun

10.  GSTM1, GSTT1, GSTP1, and GSTA1 genetic variants are not associated with coronary artery disease in Taiwan.

Authors:  Hseng-Long Yeh; Li-Tang Kuo; Fung-Chang Sung; Cheng-Wen Chiang; Chih-Ching Yeh
Journal:  Gene       Date:  2013-04-06       Impact factor: 3.688

View more
  4 in total

1.  Do GSTM1 and GSTT1 polymorphisms influence the risk of developing mitochondrial diseases in a Tunisian population?

Authors:  Raouia Ghorbel; Ghada Ben Salah; Rania Ghorbel; Afif Ben Mahmoud; Imen Chamkha; Emna Mkaouar-Rebai; Leila Ammar-Keskes; Faiza Fakhfakh
Journal:  Environ Sci Pollut Res Int       Date:  2017-12-12       Impact factor: 4.223

2.  Evaluation of glutathione S-transferase P1 (GSTP1) Ile105Val polymorphism and susceptibility to type 2 diabetes mellitus, a meta-analysis.

Authors:  Mostafa Saadat
Journal:  EXCLI J       Date:  2017-11-06       Impact factor: 4.068

Review 3.  Oxidative Stress Genes, Antioxidants and Coronary Artery Disease in Type 2 Diabetes Mellitus.

Authors:  Miha Tibaut; Daniel Petrovič
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2016

4.  GSTT1 and GSTM1 null variants in Mestizo and Amerindian populations from northwestern Mexico and a literature review.

Authors:  Luz Elena Palma-Cano; Emilio J Córdova; Lorena Orozco; Angélica Martínez-Hernández; Miguel Cid; Irene Leal-Berumen; Angel Licón-Trillo; Ruth Lechuga-Valles; Mauricio González-Ponce; Everardo González-Rodríguez; Verónica Moreno-Brito
Journal:  Genet Mol Biol       Date:  2017-11-06       Impact factor: 1.771

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.